Takhzyro

Lanadelumab-Flyo

7.4 High risk

Takhzyro & Hereditary angioedema

46.2%

of users reported Hereditary angioedema

48.6%

also reported Severe reaction

78.1%

are women

Most common medical consequences

Severe reaction
48.6%
Hospitalization
45.9%
Life-threatening condition
3.7%
Death
1.8%

Have you experienced any negative side effects from this medication?

Takhzyro: general information

Most common side effects (21)

Most commonly affected ages

10 - 19 years
4.0%
20 - 29 years
12.5%
30 - 39 years
14.8%
40 - 49 years
34.0%
50 - 59 years
23.7%
60 - 69 years
11.0%